Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Payoneer Global Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while Payoneer Global Inc trades at $7.13 (market cap $2.42B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 2.9× Payoneer Global Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Payoneer Global Inc for 62 Days on average.
| IONS | PAYO | |
|---|---|---|
Market Cap | $7.04B | $2.42B |
Volume | 2,977,440 | 1,032,721 |
Sector | Health | Technology |
52-Week High | $86.50 | $7.18 |
52-Week Low | $42.38 | $4.27 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $6.60B | $2.16B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Payoneer Global (PAYO) trades at $7.14, up 0.28% on the day, with a mixed technical outlook showing a bullish overall signal but bearish moving averages. Fundamentally, the company reported Q2 2026 earnings of $0.02 per share, missing estimates, but revenue grew 10% excluding interest. Recent news highlights the renewal of its partnership with Etsy through 2029 and an agreement to be acquired by Nuvei, announced on June 15, 2026.
The outlook is shaped by the pending acquisition, which offers a potential exit for shareholders, but execution risks and recent earnings misses pose concerns. Analyst sentiment is positive with a 60% buy rating, yet investors should weigh acquisition certainty against operational performance volatility and competitive pressures in the fintech sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
